Register Login
Register to leave comments
  • News bot Jan. 29, 2026, 7:41 p.m.

    📋 Atara Biotherapeutics Inc (ATRA) - Clinical Trial Update

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 16:00:16

    Event Type: Clinical Trial Update

    Event Details:

    Atara Biotherapeutics Inc (ATRA) Announces Clinical Trial Update Atara Biotherapeutics Inc (ATRA) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: leader
    • Collaboration: GMP
    • Updated Timeline: 15 January 2025

    🔬 Clinical Development Pipeline (Atara Biotherapeutics Inc):

    Product Type Development Stage Therapeutic Area Source
    A2B543 BIOLOGICAL Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    A2B694 BIOLOGICAL Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    Apheresis OTHER Preclinical Solid Tumor, Adult ClinicalTrials.gov
    GRNVAC1 BIOLOGICAL Phase PHASE2 Acute Myelogenous Leukemia ClinicalTrials.gov
    Cytomegalovirus-specific Cytotoxic T Lymphocytes (CMV-CTLs) BIOLOGICAL Preclinical CMV Viremia ClinicalTrials.gov
    WT1-sensitized T cells BIOLOGICAL Phase PHASE1 Leukemia ClinicalTrials.gov
    CMV-pp65 CTLs BIOLOGICAL Phase PHASE2 Cytomegalovirus ClinicalTrials.gov
    tabelecleucel BIOLOGICAL Preclinical Epstein-Barr Virus (EBV) Infections ClinicalTrials.gov
    EBV-specific T cells (EBV-CTLs) BIOLOGICAL Phase PHASE2 EBV-induced Lymphomas ClinicalTrials.gov
    Epstein-Barr virus-specific cytotoxic T lymphocytes (EBV-CTLs) BIOLOGICAL Phase PHASE1 EBV-induced Lymphomas ClinicalTrials.gov
    Placebo DRUG Phase PHASE1 Primary Progressive Multiple Sclerosis ClinicalTrials.gov
    ATA188 BIOLOGICAL Phase PHASE1 Primary Progressive Multiple Sclerosis ClinicalTrials.gov
    Fludarabine DRUG Phase PHASE1 Rheumatoid Arthritis ClinicalTrials.gov
    Cyclophosphamide DRUG Phase PHASE1 Rheumatoid Arthritis ClinicalTrials.gov
    Rituximab DRUG Phase PHASE1 Rheumatoid Arthritis ClinicalTrials.gov
    AB-101 DRUG Phase PHASE1 Rheumatoid Arthritis ClinicalTrials.gov
    pembrolizumab BIOLOGICAL Phase PHASE1 Solid Tumor ClinicalTrials.gov
    etakafusp alfa (AB248) BIOLOGICAL Phase PHASE1 Solid Tumor ClinicalTrials.gov
    FB418 DRUG Phase PHASE1 Parkinson Disease Psychosis ClinicalTrials.gov
    GCC2005 DRUG Phase PHASE1 Lymphoma, T-Cell ClinicalTrials.gov
    ATA3219 DRUG Phase PHASE1 Lupus Nephritis ClinicalTrials.gov
    CAR T cells BIOLOGICAL Phase PHASE1 Malignant Pleural Mesothelioma (MPM) ClinicalTrials.gov
    AB821 DRUG Phase PHASE1 Advanced Melanoma and Normal or Impaired ClinicalTrials.gov
    REMD-477 DRUG Phase PHASE2 Type 1 Diabetes ClinicalTrials.gov
    Obinutuzumab DRUG Phase PHASE1 Lupus Nephritis - WHO Class III ClinicalTrials.gov
    Interleukin-2 DRUG Phase PHASE2 Relapsed or Refractory Hodgkin Lymphoma ClinicalTrials.gov
    AFM13 DRUG Phase PHASE2 Relapsed or Refractory Hodgkin Lymphoma ClinicalTrials.gov
    Allogeneic NK Cells DRUG Phase PHASE2 Refractory Rheumatoid Arthritis (RA) ClinicalTrials.gov
    A2B530 BIOLOGICAL Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    WP1302 placebo DRUG Phase PHASE2 Graves Disease ClinicalTrials.gov
    WP1302 DRUG Phase PHASE2 Graves Disease ClinicalTrials.gov
    No additional intervention administered in this long term follow-up study OTHER Preclinical Solid Tumor Cancer ClinicalTrials.gov
    A2B395 BIOLOGICAL Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    Phase IIb dose-expansion part of FB849 in Combination with Pembrolizumab (Type C cancer) DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Phase IIb dose-expansion part of FB849 in Combination with Pembrolizumab (Type B cancer) DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Phase IIb dose-expansion part of FB849 in Combination with Pembrolizumab (Type A cancer) DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Phase IIb dose-escalation part of FB849 in Combination with Pembrolizumab DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Phase Ib dose-expansion of FB849 monotherapy DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Phase Ia dose-escalation part of FB849 Monotherapy DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Bendamustine DRUG Phase PHASE1 Non Hodgkin Lymphoma ClinicalTrials.gov
    AB-201 DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov
    Volagidemab BIOLOGICAL Phase PHASE1 Type 1 Diabetes Mellitus ClinicalTrials.gov
    Placebo for FB-101 DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    FB-101 DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Muscle Biopsy PROCEDURE Phase PHASE2 Pre Diabetes ClinicalTrials.gov
    Hyperinsulemic euglycemic clamp OTHER Phase PHASE2 Pre Diabetes ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Atara Biotherapeutics Inc
    • Ticker Symbol: ATRA

Search

News categories